Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 800 results for "rodman"

Rodman & Renshaw Prescribe A $6 Price Target For Cancer Genetics

Cancer Genetics Inc (NASDAQ: CGIX ) represents a highly differentiated investment opportunity, given its broad pipeline of tests…and with its ability to generate high-margin revenue from partnerships with biopharmaceutical firms that are seeking ... Benzinga.com, 1 day ago

502 images for rodman

ChannelLife NZ, 6 days ago
Mideast Time, 8 hours ago
Philadelphia Magazine, 1 week ago
WKRB News, 18 hours ago
Octafinance, 1 day ago
American Banking News, 1 day ago
American Banking News, 1 day ago
WKRB News, 1 day ago
Naval Technology, 4 days ago
Zolmax News, 1 day ago
Naval Technology

Rodman Polyships-Fast Patrol Boats and Vessels

Since 1974, has designed and constructed Glass-Reinforced Plastic (GRP) and composite-material fast patrol boats and fast patrol vessels for naval, maritime surveillance and maritime law enforcement applications. Rodman provides a wide range of ...
 Naval Technology4 days ago
Pharma Focus Asia

Citius Pharmaceuticals to Present at the Rodman & Renshaw 18th Annual Global Investment Conference

By a News Reporter-Staff News Editor at Investment Weekly News Citius Pharmaceuticals, Inc. ("Citius") (OTC QB: CTXR), a specialty pharmaceutical company dedicated to developing and commercializing adjunctive cancer care and critical care drug ...
 Pharmacy Choice3 days ago Intellipharmaceutics to Present at the 18th Annual Rodman & Renshaw Global Investment Conference [Jerusalem Post (Israel)]  Pharmacy Choice4 days ago Rodman CPAs' Kathy Parker to Speak at National Biogas Conference in Orlando  SPi World News5 days ago Rexahn Pharmaceuticals to Present at 18th Annual Rodman & Renshaw Global Investment Conference on September 12, 2016 [Jerusalem Post (Israel)]  Pharmacy Choice2 days ago
[x]  

Vuzix to Participate in Several Upcoming September Investor Events

Upcoming events include the Oppenheimer Investor Drone Day, Rodman & Renshaw 18th Annual Global Investment Conference and Dougherty & Company Institutional Investor Conference ROCHESTER, N.Y. , Sept. 1, 2016 /PRNewswire/ --Vuzix® Corporation ...
 Benzinga.com1 week ago

4 - Rodman David Malcom (0001672659) (Reporting)

Form 4 - Statement of changes in beneficial ownership of securities SEC Accession No. 0001104659-16-144636 Filing Date 2016-09-14 2016-09-14 16:16:18 Period of Report 2016-09-12 Filing Date Changed 2016-09-14 Document Format Files ...
 SEC Filings1 week ago

Plug Power's (PLUG) CEO Andrew Marsh Presents at Rodman & Renshaw Global Investment Conference (Transcript)

Plug Power Inc. (NASDAQ: PLUG ) Rodman & Renshaw Global Investment Conference Call September 13, 2016 9:10 AM ET Executives Andrew Marsh Chief Executive Officer Analysts Unidentified Company Representative Good morning, ...
 Seeking Alpha2 weeks ago Plug Power CEO Andy Marsh to Speak at Rodman & Renshaw 18th Annual Global Investment Conference  4 Traders2 weeks ago
[x]  
Octafinance

Aytu BioScience (UNKNOWN:AYTU) Now Covered by Analysts at Rodman & Renshaw. The Stock has $9.00 Price Objective

Aytu BioScience (UNKNOWN:AYTU) Price Target & New Coverage by Rodman & Renshaw Stock analysts at Rodman & Renshaw placed Buy rating on Aytu BioScience (UNKNOWN:AYTU). The firm has begun coverage in an analyst report revealed to investors on ...
 Octafinance1 day ago Rodman & Renshaw Starts Cancer Genetics (NYSE:CGIX) Coverage With Buy Rating and $6.00 Target Price per Share  Octafinance1 day ago Aytu Bioscience Inc (AYTU) Coverage Initiated at Rodman & Renshaw  American Banking News1 day ago Rodman & Renshaw Initiates Coverage on Aytu Bioscience Inc (AYTU)  American Banking News1 day ago
[x]  

Arch Therapeutics, Inc. (ARTH: OTCQB) | Arch Therapeutics Provides Corporate Update at the 18th Annual Rodman & Renshaw Global Investment Conference

- Arch Therapeutics, Inc. (OTCQB: ARTH) (" Arch " or the " Company "), developer of AC5 devices for use in controlling bleeding and fluid loss in order to provide faster and safer surgical and interventional care, was featured as a presenting ...
 OTC Markets2 weeks ago ARCH THERAPEUTICS : Provides Corporate Update at the 18th Annual Rodman & Renshaw Global Investment Conference  4 Traders2 weeks ago Arch Therapeutics Provides Corporate Update at the 18th Annual Rodman & Renshaw Global Investment Conference  Yahoo! Finance UK and Ireland2 weeks ago
[x]  

Wells Compliance Group to Sponsor Rodman & Renshaw Annual Global Investment Conference

, a technology-based services firm supporting the financial reporting needs of emerging growth and small-cap companies, will be a sponsor of the Rodman & Renshaw Annual Global Investment Conference being held in New York City from September 12-13 at ...
 Minyanville2 weeks ago
[x]  

Cancer Genetics Inc. (CGIX) Coverage Initiated by Analysts at Rodman & Renshaw

Research analysts at Rodman & Renshaw began coverage on shares of Cancer Genetics Inc. (NASDAQ:CGIX) Separately, Zacks Investment Research raised Cancer Genetics from a hold rating to a buy rating and set a $2.25 price objective on the stock in a ...
 American Banking News1 day ago Cancer Genetics Inc. (CGIX) Now Covered by Analysts at Rodman & Renshaw  Mideast Time9 hours ago Cancer Genetics Inc. (CGIX) Receives New Coverage from Analysts at HC Wainwright  American Banking News14 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - rodman
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less